Workflow
Till cell therapy
icon
Search documents
Iovance Biotherapeutics(IOVA) - 2025 Q1 - Earnings Call Transcript
2025-05-08 21:32
Iovance Biotherapeutics (IOVA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Sara Pellegrino - Senior Vice President, Investor Relations and Corporate CommunicationsFrederick Vogt - Interim CEO, President, General Counsel, Corporate Secretary & DirectorDan Kirby - Chief Commercial OfficerIgor Bilinsky - Chief Operating OfficerJean-Marc Bellemin - Chief Financial OfficerFriedrich Graf Finckenstein - Chief Medical OfficerAndrew Tsai - SVPSalim Syed - Managing Director, Equity ResearchAnd ...
Iovance Biotherapeutics(IOVA) - 2025 Q1 - Earnings Call Transcript
2025-05-08 21:30
Iovance Biotherapeutics (IOVA) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 Good day and thank you for standing by. Welcome to the Iovance Biotherapeutics First Quarter twenty twenty five Financial Results Conference Call. At this time, participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. To ask a question during the session, you will press 11 on your telephone. You will then hear an automated message advising your hand is raised. ...